Kymera
phase trial design parts a part | Kymera
Company
Deck Type
Sector
Industry
Deck date
December 2022
Slide
27 of 63
Related slides by other companies
ATAI
Investor Presentation
April 2023
summary has previously shown pro cognitive effects in | ATAI
Ocuphire Pharma
Results
October 2022
safety summary from phase and phase trials | Ocuphire Pharma
ATAI
Investor Presentation
June 2020
summary phase trial showed a rapid sustained reduction in depressive symptoms | ATAI
Larimar Therapeutics
Investor Presentation
November 2023
appeared to be generally well tolerated in phase trial cohort | Larimar Therapeutics
Other recent decks by Kymera
See all presentations (7 decks)
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights